IL33-mediated NPM1 promotes fibroblast-to-myofibroblast transition via ERK/AP-1 signaling in silica-induced pulmonary fibrosis
Toxicological Sciences · 29.08.2023 · 195 (1) · 71-86
DOI: 10.1093/toxsci/kfad061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 03.07.2023. Verfasst von Yue Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, N…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Silicosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Postdoctoral Research Supportive Project of Suzhou College of Nanjing Medical University 2021.
Abstract (Originalsprache)
Silicosis is a global occupational pulmonary disease due to the accumulation of silica dust in the lung. Lacking effective clinical drugs makes the treatment of this disease quite challenging in clinics largely because the pathogenic mechanisms remain obscure. Interleukin 33 (IL33), a pleiotropic cytokine, could promote wound healing and tissue repair via the receptor ST2. However, the mechanisms governing the involvement of IL33 in silicosis progression remain to be further explored. Here, we demonstrated that the IL33 levels in the lung sections were significantly overexpressed after bleomycin and silica treatment. Chromatin immunoprecipitation assay, knockdown, and reverse experiments were performed in lung fibroblasts to prove gene interaction following exogenous IL33 treatment or cocultured with silica-treated lung epithelial cells. Mechanistically, we illustrated that silica-stimulated lung epithelial cells secreted IL33 and further promoted the activation, proliferation, and migration of pulmonary fibroblasts by activating the ERK/AP-1/NPM1 signaling pathway in vitro. And more, treatment with NPM1 siRNA-loaded liposomes markedly protected mice from silica-induced pulmonary fibrosis in vivo. In conclusion, the involvement of NPM1 in the progression of silicosis is regulated by the IL33/ERK/AP-1 signaling axis, which is the potential therapeutic target candidate in developing novel antifibrotic strategies for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
- Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China.
- Gusu School, Nanjing Medical University, Nanjing 211166, China.
ORCID-Profile: Chunhui Ni
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Postdoctoral Research Supportive Project of Suzhou College of Nanjing Medical University 2021
Zitieren
APA
Wang, Y., Cheng, D., Li, Z., Sun, W., Zhou, S., Peng, L., Xiong, H., Jia, X., Li, W., Han, L., Liu, Y., & Ni, C. (2023). IL33-mediated NPM1 promotes fibroblast-to-myofibroblast transition via ERK/AP-1 signaling in silica-induced pulmonary fibrosis. Toxicological Sciences, 195(1), 71-86. https://doi.org/10.1093/toxsci/kfad061
Vancouver
Wang Y, Cheng D, Li Z, Sun W, Zhou S, Peng L, et al. IL33-mediated NPM1 promotes fibroblast-to-myofibroblast transition via ERK/AP-1 signaling in silica-induced pulmonary fibrosis. Toxicological Sciences. 2023;195(1):71-86. doi:10.1093/toxsci/kfad061
BibTeX
@article{Wang2023,
author = {Wang, Yue and Cheng, Demin and Li, Ziwei and Sun, Wenqing and Zhou, Siyun and Peng, Lan and Xiong, Haojie and Jia, Xinying and Li, Wei and Han, Lei and Liu, Yi and Ni, Chunhui},
title = {IL33-mediated NPM1 promotes fibroblast-to-myofibroblast transition via ERK/AP-1 signaling in silica-induced pulmonary fibrosis},
journal = {Toxicological Sciences},
year = {2023},
volume = {195},
number = {1},
pages = {71--86},
doi = {10.1093/toxsci/kfad061}
}
EUVIMED